ABSTRACT OF THE THESIS Background: There were an estimated 300,000 new HIV infections in the Asia and Pacific region in 2015, with young people aged 15 to 24 years accounting for 37% of all new HIV infections. The number of adolescents living with HIV has risen by 28% between 2005 and 2015 in this region. The HIV/AIDS-related knowledge, attitudes, behavior and HIV testing status study was done among young people aged 15 to 24 years in Myanmar, 2016. Objectives: To assess the knowledge, attitude, behavior, and HIV testing status among young people of Myanmar. Methods: The study was a cross-sectional study; it was a nationally representative survey of women and men age 15-24 year throughout Myanmar, data based on 2015-16 Myanmar Demographic and Health Survey (MDHS). A total of 3,728 women and 1,458 men were interviewed to examine knowledge, awareness, and behavior regarding HIV/AIDS and other sexually transmitted infections (STIs). The survey used computer-assisted field editing (CAFE) procedures. SAS software 9.4 used for data management and analyses. Results: The young people in the study group have the high awareness about HIV, but limited knowledge about HIV/ AIDS prevention which varied across residence and education level. The stigma and discrimination of HIV/AIDS still prevalent among young people. The prevalence of HIV testing was low among young men. Conclusion: HIV related knowledge, attitude and behavior among young people is the key area to focus on young people living in the rural area with low education and income in Myanmar. The policymakers and HIV program managers should focus on the most vulnerable groups on HIV prevention by awareness raising campaign and by creating an enabling environment for HIV counseling and testing. Keywords: HIV/AIDS, Knowledge, Attitude and Practice, Young People

The evaluation of reproductive, maternal, newborn, and child health (RMNCH) by the Disease Control Priorities, Third Edition (DCP3) focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and influences to pregnancy and pre-pregnancy. Volume 3 focuses on developments since the publication of DCP2 and will also include the transition to older childhood, in particular, the overlap and commonality with the child development volume. The DCP3 evaluation of these conditions produced three key findings: 1. There is significant difficulty in measuring the burden of key conditions such as unintended pregnancy, unsafe abortion, nonsexually transmitted infections, infertility, and violence against women. 2. Investments in the continuum of care can have significant returns for improved and equitable access, health, poverty, and health systems. 3. There is a large difference in how RMNCH conditions affect different income groups; investments in RMNCH can lessen the disparity in terms of both health and financial risk.

A global economic analysis of HIV infection amongst sex workers, finding that evidence based and rights affirming interventions are not implemented to the level that their efficacy warrants, and that doing so at scale would be cost effective and deliver significant returns on investment.

It is estimated that by the end of 2003 there were just under 38 million people living with HIV/AIDS, with all but two million of these people of working age. This report, prepared by the ILO Programme on HIV/AIDS and the World of Work, sets out global estimates of the impact of HIV/AIDS on the labour force and the working age population in 50 countries in Africa, Asia, Latin America and the Caribbean and in more developed regions. Issues discussed include: the implications for the private and public sectors, on agriculture and concerns for food insecurity and on the informal economy; on women and children; policy implications and examples of responses to the problem in a variety of workplace settings; provision of antiretroviral therapy in conjunction with HIV prevention in the workplace and the potential for expanded access to workplace-based treatment.